Literature DB >> 25746700

The impact of children's hospital designation on outcomes in children with malrotation.

Afif N Kulaylat1, Christopher S Hollenbeak2, Brett W Engbrecht3, Peter W Dillon3, Shawn D Safford3.   

Abstract

BACKGROUND: The benefit of Ladd's procedure for malrotation at a Children's Hospital (CH) has not previously been established. Our aim was to characterize the potential variations in management and outcomes between CH and Non-Children's Hospitals (NCH) in the treatment of malrotation with Ladd's procedure.
METHODS: There were 2827 children identified with malrotation and complete information from the Kids' Inpatient Database (2003, 2006, 2009). Outcomes were compared between CH and NCH and evaluated with logistic and linear regressions. Additional propensity score matching was used to balance covariates between CH and NCH.
RESULTS: There were 2261 (80.0%) children with malrotation undergoing Ladd's procedures treated at CH; 566 (20.0%) were treated at NCH. In multivariate analysis, CH was associated with a 39% lower odds of resection (p=0.004), with no differences observed for mortality, morbidity and LOS. Comparison of a propensity score matched cohort confirmed these findings, as well as demonstrated no significant differences in associated costs.
CONCLUSIONS: The majority of pediatric intestinal malrotation is managed at CH. While measured outcomes of mortality, morbidity, LOS, and costs were not different at NCH, CH was less likely to perform intestinal resection during Ladd's procedure.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children's Hospital; Hospital designation; Intestinal malrotation; Kids' Inpatient Database; Ladd's procedure; Volvulus

Mesh:

Year:  2014        PMID: 25746700     DOI: 10.1016/j.jpedsurg.2014.08.011

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Technology-Dependent Pediatric Inpatients at Children's Versus Nonchildren's Hospitals.

Authors:  Namrata Ahuja; Wendy J Mack; Christopher J Russell
Journal:  Hosp Pediatr       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.